Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meng Liu
Institutions:
Shandong University of Traditional Chinese Medicine,
Shandong Tumor Hospital,
Shandong Provincial QianFoShan Hospital,
Shandong First Medical University
Observed institutions:
Shandong University of Traditional Chinese Medicine,
Shandong University,
Shandong Tumor Hospital,
Shandong Provincial QianFoShan Hospital,
Shandong First Medical University
ORCID:
0000-0003-0302-3825
Observed ORCID:
0000-0003-0302-3825
OpenAlex ID:
A5062027763
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity
2022
·
Meng Liu
, Shan Gao
, et al.
·
Journal of Medicinal Chemistry
·
46
Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death
2024
·
Meng Liu
, Shan Gao
, et al.
·
Journal of Medicinal Chemistry
·
18
Discovery of a Novel HDAC1 Inhibitor to Potentiate Ferroptosis with Arachidonic Acid in ESCC
2026
·
Meng Liu
, Shan Gao
, et al.
·
Journal of Medicinal Chemistry
Design, Synthesis, and Evaluation of Benzimidazole-Based HDAC Inhibitors: Synergistic Effect with FLT3 Inhibitor against AML via Modulation of Tumor Metabolism
2026
·
Meng Liu
, Junxin Xue
, et al.
·
Journal of Medicinal Chemistry
Show more works
View as search
Works count:
4
Citation count:
64
H-index:
2
I10-index:
2
Year
Topic
Type